NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.

4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.

Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards

For the second year running, Patchs Health has been recognised at the Health Tech Digital Awards.

The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.

Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.